CLOVER BIO-B News

CLOVER BIO-B: Form of Proxy for Use at Annual General Meeting

Apr 25 07:46 ET

CLOVER BIO-B: (1). Proposed Grant of General Mandates to Repurchase Shares and to Issue New Shares; (2). Proposed Re-Election of the Retiring Directors; (3). Proposed Re-Appointment of Auditor; (4). Proposed Amendments to the Memorandum And Articles of Association; A

Apr 25 07:41 ET

CLOVER BIO-B: Notice of Annual General Meeting

Apr 25 07:16 ET

CLOVER BIO-B: 2023 Annual Report

Apr 25 07:13 ET

CLOVER BIO-B: VOLUNTARY ANNOUNCEMENT CLOVER ANNOUNCES POSITIVE PRELIMINARY PHASE I RESULTS FOR BIVALENT RSV VACCINE CANDIDATE SCB-1019 IN INITIAL YOUNG ADULT COHORT

Apr 8 05:02 ET

CLOVER BIO-B: Monthly Return of Equity Issuer on Movements in Securities for the Month ended March 31, 2024

Apr 3 05:14 ET

CLOVER BIO-B: GRANT OF OPTIONS PURSUANT TO THE POST-IPO SHARE OPTION PLAN AND GRANT OF RSUS PURSUANT TO THE RSU SCHEME

Apr 2 10:26 ET

CLOVER BIO-B: ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2023 AND PROPOSED AMENDMENTS TO THE MEMORANDUM AND ARTICLES OF ASSOCIATION

Mar 26 18:08 ET

CLOVER BIO-B: DATE OF BOARD MEETING

Mar 14 04:33 ET

CLOVER BIO-B: Monthly Return of Equity Issuer on Movements in Securities for the Month ended February 29, 2024

Mar 4 02:12 ET

CLOVER BIO-B: Letter to Non-Registered Shareholders - Arrangement of Electronic Dissemination of Corporate Communications and Reply Form

Feb 22 03:36 ET

CLOVER BIO-B: Letter to Registered Shareholders - Arrangement of Electronic Dissemination of Corporate Communications and Reply Form

Feb 22 03:35 ET

CLOVER BIO-B: Monthly Return of Equity Issuer on Movements in Securities for the Month ended January 31, 2024

Feb 1 21:51 ET

CLOVER BIO-B: Monthly Return of Equity Issuer on Movements in Securities for the Month ended December 31, 2023

Jan 2 22:03 ET

CLOVER BIO-B: VOLUNTARY ANNOUNCEMENT - CLOVER ANNOUNCES POSITIVE PHASE I RESULTS FOR SCB-219M FOR TREATMENT OF CHEMOTHERAPY-INDUCED THROMBOCYTOPENIA (CIT)

Dec 28, 2023 18:00 ET

CLOVER BIO-B: GRANT OF EXTENSION OF WAIVER FROM STRICT COMPLIANCE WITH RULE 14A.53 OF THE LISTING RULES UNDER THE LICENSE AGREEMENT

Dec 27, 2023 17:05 ET

CLOVER BIO-B: VOLUNTARY ANNOUNCEMENT - CLOVER INITIATES PHASE I CLINICAL TRIAL FOR RSV VACCINE CANDIDATE

Dec 12, 2023 18:31 ET

CLOVER BIO-B: Monthly Return of Equity Issuer on Movements in Securities for the Month ended November 30, 2023

Dec 5, 2023 01:29 ET

CLOVER BIO-B: VOLUNTARY ANNOUNCEMENT - CLOVER COMPLETES BLA SUBMISSION FOR SEASONAL INFLUENZA VACCINE IN BRAZIL

Nov 6, 2023 18:45 ET

CLOVER BIO-B: Monthly Return of Equity Issuer on Movements in Securities for the Month ended October 31, 2023

Nov 2, 2023 05:56 ET